248 related articles for article (PubMed ID: 34464993)
21. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
[TBL] [Abstract][Full Text] [Related]
22. Relationship between gut microbiome Fusobacterium nucleatum and LINE-1 methylation level in esophageal cancer.
Baba Y; Hara Y; Toihata T; Kosumi K; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Komohara Y; Baba H
Esophagus; 2023 Oct; 20(4):704-712. PubMed ID: 37173453
[TBL] [Abstract][Full Text] [Related]
23.
Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer.
Kurt M; Yumuk Z
Sci Rep; 2021 Jan; 11(1):1608. PubMed ID: 33452405
[TBL] [Abstract][Full Text] [Related]
25. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.
Haruki K; Kosumi K; Hamada T; Twombly TS; Väyrynen JP; Kim SA; Masugi Y; Qian ZR; Mima K; Baba Y; da Silva A; Borowsky J; Arima K; Fujiyoshi K; Lau MC; Li P; Guo C; Chen Y; Song M; Nowak JA; Nishihara R; Yanaga K; Zhang X; Wu K; Bullman S; Garrett WS; Huttenhower C; Meyerhardt JA; Giannakis M; Chan AT; Fuchs CS; Ogino S
J Pathol; 2020 Apr; 250(4):397-408. PubMed ID: 31880318
[TBL] [Abstract][Full Text] [Related]
26. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
[TBL] [Abstract][Full Text] [Related]
27. Prediagnostic Antibody Responses to
Lo CH; Blot WJ; Teras LR; Visvanathan K; Le Marchand L; Haiman CA; Chen Y; Sesso HD; Wassertheil-Smoller S; Tinker LF; Peek RM; Potter JD; Cover TL; Zeleniuch-Jacquotte A; Berndt SI; Waterboer T; Epplein M; Butt J; Song M
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1279-1282. PubMed ID: 33737297
[TBL] [Abstract][Full Text] [Related]
28.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
29. Replication Study:
Repass J;
Elife; 2018 Mar; 7():. PubMed ID: 29533182
[TBL] [Abstract][Full Text] [Related]
30.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
31. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
32. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
[TBL] [Abstract][Full Text] [Related]
33. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.
Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A
Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953
[TBL] [Abstract][Full Text] [Related]
34. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
35. Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis.
Hayashi M; Ikenaga N; Nakata K; Luo H; Zhong P; Date S; Oyama K; Higashijima N; Kubo A; Iwamoto C; Torata N; Abe T; Yamada Y; Ohuchida K; Oda Y; Nakamura M
Cancer Sci; 2023 Sep; 114(9):3666-3678. PubMed ID: 37438965
[TBL] [Abstract][Full Text] [Related]
36. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
37. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
38. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
39. Genetic Transformation of Fusobacterium nucleatum.
Yoshida A; Ikegami A
Methods Mol Biol; 2021; 2210():43-50. PubMed ID: 32815126
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis.
Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X
Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]